COSYNTROPIN

Product NDC
51662-1567
11-digit product format
516621567
Labeler code
51662
Product ID
51662-1567_120401a8-c1c7-581c-e063-6294a90a94f8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
COSYNTROPIN
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Application
ANDA202147
Marketing category
ANDA
Marketing start
2021-07-10
Substance
COSYNTROPIN
Active strength
.25 mg/mL
Pharmacologic classes
Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
COSYNTROPIN
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
COSYNTROPIN.25 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii72YY86EA29

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
270ccf93-a074-eb32-7414-3afc7e6f80eaProduct name120140508
ef89d5cf-69c1-2a97-8bab-e66260f923c2Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1567-1COSYNTROPIN1 mL in 1 VIALINJECTION, POWDER, LYOPHILIZED,12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1567COSYNTROPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]2Current NDC, Legacy NDC, 1 package rows20240224_c6cf2223-4a93-0b28-e053-2a95a90ade53.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51662-1567-1516621567011 mL in 1 VIAL (51662-1567-1) 1 ml2021-07-100000-00-00NoNoCurrent